Share:
Peer-Reviewed Publication
Contemp Clin Trials Commun2025;43101387.February 1, 2025Journal Article

Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patients.

Laura C Schubel1, Ana Barac2, Michelle Magee3,4, Mihriye Mete1,5, Malinda Peeples6, Mansur Shomali6, Kristen E Miller1, Lauren R Bangerter1,7, Allan Fong5, Christopher Gallagher8, Jeanne Mandelblatt9, Hannah Arem1,10
1Healthcare Delivery Research, MedStar Health Research Institute, Washington, DC, USA.
2Heart and Vascular Institute Inova Health System, Falls Church, VA, USA.
3School of Medicine, Georgetown University, Washington, DC, USA.
4Diabetes Institute, MedStar Washington Hospital Center, Washington, DC, USA.
5Center for Biostatistics, Informatics, and Data Science School of Medicine, Georgetown University, Washington, DC, USA.
6WellDoc, Inc, Columbia, MD, USA.
7Health Economics and Aging Research Institute, MedStar Health, Washington, DC, USA.
8MedStar Washington Hospital Center, Washington, DC, USA.
9Lombardi Comprehensive Cancer Center, Institute for Cancer and Aging REsearch (I-CARE), School of Medicine, Georgetown University, Washington, DC, USA.
10Department of Oncology, Georgetown University, Washington, DC, USA.

Abstract

BACKGROUND: Black individuals with cancer have a higher prevalence of comorbidities and a worse cancer prognosis than other racial groups in the US. As part of a quality improvement project, we aimed to demonstrate feasibility of self-monitoring and community health worker (CHW) support among managing comorbidities for Black individuals with breast or prostate cancer. METHODS: In a single arm, pr…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.